Publications

About phages

Veterinary Products

Micromir today

EN

RU

Publishing

A New Clinical Approach to Combating Antibiotic Resistance in Intensive Care

Researchers from leading Russian clinical and research institutions, together with scientists from RPC Micromir, present the results of a clinical study

FDA approves phage therapy for COVID-19 patients

The US Food and Drug Administration (FDA) has given the green light to the use of phage therapy for patients with severe COVID-19.

In Russia, the first patent was issued for the treatment of nosocomial pneumonia with bacteriophages

Scientists of the RPC "Micromir" received it together with the Federal State Budgetary Scientific Institution "Federal Scientific and Clinical Center of Intensive Care Medicine and Rehabilitology" (FSCC ICMR).

Comparison of the effectiveness of bacteriophages with antibiotics in rearing broiler chickens

A team of scientists from RPC "Micromir" publishes the results of the use of the veterinary drug "Phagovet" in real production conditions

RPC "Micromir" will study the effectiveness of the "Phagodent"preparation in space

Scientists are investigating the effectiveness of a bacteriophage-based preparation for controlling and correcting the microbiocenosis of the oral cavity and oropharynx

© RPC "Micromir" - an eco-friendly approach to microbiome regulation

Navigation

Micromir today

Veterinary Products

About phages

Publications

Products

Phagouterin

Phagovet

+7 495 625-32-65

office@micromir.bio

Personal data processing policy

Оферта

Details

By using this site, you consent to the use of cookies to help us make it more convenient for you. Read our personal data processing policy

OK